Intelligent Bio Solutions (INBS) Competitors

$2.78 -0.05 (-1.63%)

As of 11:21 AM Eastern

INBS vs. FEMY, POAI, RVP, ICCM, and OSRH

Should you buy Intelligent Bio Solutions stock or one of its competitors? MarketBeat compares Intelligent Bio Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Intelligent Bio Solutions include Femasys (FEMY), Predictive Oncology (POAI), Retractable Technologies (RVP), IceCure Medical (ICCM), and OSR (OSRH). These companies are all part of the "medical equipment" industry.

How does Intelligent Bio Solutions compare to Femasys?

Femasys (NASDAQ:FEMY) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

Intelligent Bio Solutions has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	8.94	-$18.63M	-$0.27	N/A
Intelligent Bio Solutions	$3.05M	2.18	-$10.57M	-$12.22	N/A

65.3% of Femasys shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 7.6% of Femasys shares are owned by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Intelligent Bio Solutions has a net margin of -296.73% compared to Femasys' net margin of -521.97%. Intelligent Bio Solutions' return on equity of -176.09% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Femasys has a beta of -2.26, suggesting that its stock price is 326% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.24, suggesting that its stock price is 324% more volatile than the broader market.

Femasys currently has a consensus target price of $5.33, indicating a potential upside of 1,473.25%. Given Femasys' stronger consensus rating and higher possible upside, equities research analysts clearly believe Femasys is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Femasys had 1 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 2 mentions for Femasys and 1 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.19 beat Femasys' score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Femasys	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Femasys beats Intelligent Bio Solutions on 9 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Predictive Oncology?

Intelligent Bio Solutions (NASDAQ:INBS) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Intelligent Bio Solutions has a net margin of -296.73% compared to Predictive Oncology's net margin of -5,065.23%. Intelligent Bio Solutions' return on equity of -176.09% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Predictive Oncology	-5,065.23%	-732.73%	-235.55%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 1.2% of Predictive Oncology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Intelligent Bio Solutions and Intelligent Bio Solutions both had 1 articles in the media. Intelligent Bio Solutions' average media sentiment score of 1.19 beat Predictive Oncology's score of 0.75 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Predictive Oncology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Intelligent Bio Solutions has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	2.18	-$10.57M	-$12.22	N/A
Predictive Oncology	$1.66M	10.46	-$12.66M	-$13.50	N/A

Intelligent Bio Solutions has a beta of 4.24, indicating that its share price is 324% more volatile than the broader market. Comparatively, Predictive Oncology has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

Summary

Intelligent Bio Solutions beats Predictive Oncology on 11 of the 12 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

Retractable Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.24, meaning that its stock price is 324% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Retractable Technologies has higher revenue and earnings than Intelligent Bio Solutions. Retractable Technologies is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Intelligent Bio Solutions	$3.05M	2.18	-$10.57M	-$12.22	N/A

In the previous week, Retractable Technologies and Retractable Technologies both had 1 articles in the media. Intelligent Bio Solutions' average media sentiment score of 1.19 beat Retractable Technologies' score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Retractable Technologies has a net margin of -41.11% compared to Intelligent Bio Solutions' net margin of -296.73%. Retractable Technologies' return on equity of -17.15% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Retractable Technologies beats Intelligent Bio Solutions on 7 of the 13 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to IceCure Medical?

Intelligent Bio Solutions (NASDAQ:INBS) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Intelligent Bio Solutions has higher earnings, but lower revenue than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	2.18	-$10.57M	-$12.22	N/A
IceCure Medical	$3.38M	5.62	-$15.06M	-$0.24	N/A

In the previous week, IceCure Medical had 8 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 9 mentions for IceCure Medical and 1 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.19 beat IceCure Medical's score of -0.51 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IceCure Medical	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Intelligent Bio Solutions has a beta of 4.24, suggesting that its share price is 324% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market.

Intelligent Bio Solutions has a net margin of -296.73% compared to IceCure Medical's net margin of -441.60%. Intelligent Bio Solutions' return on equity of -176.09% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
IceCure Medical	-441.60%	-211.73%	-119.13%

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 2.4% of IceCure Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

IceCure Medical has a consensus price target of $2.09, suggesting a potential upside of 793.16%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Intelligent Bio Solutions and IceCure Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to OSR?

OSR (NASDAQ:OSRH) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, media sentiment, valuation and risk.

OSR has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.24, meaning that its share price is 324% more volatile than the broader market.

In the previous week, Intelligent Bio Solutions had 1 more articles in the media than OSR. MarketBeat recorded 1 mentions for Intelligent Bio Solutions and 0 mentions for OSR. Intelligent Bio Solutions' average media sentiment score of 1.19 beat OSR's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
OSR	Neutral
Intelligent Bio Solutions	Positive

55.3% of OSR shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Intelligent Bio Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Intelligent Bio Solutions has higher revenue and earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91M	6.10	-$27.06M	-$0.33	N/A
Intelligent Bio Solutions	$3.05M	2.18	-$10.57M	-$12.22	N/A

Intelligent Bio Solutions has a net margin of -296.73% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Summary

Intelligent Bio Solutions beats OSR on 7 of the 13 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INBS vs. The Competition

Export

Metric	Intelligent Bio Solutions	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.65M	$8.20B	$6.29B	$12.20B
Dividend Yield	N/A	3.19%	2.80%	5.36%
P/E Ratio	-0.23	21.12	20.81	25.32
Price / Sales	2.18	16.50	520.43	71.72
Price / Cash	N/A	80.63	43.18	55.00
Price / Book	0.76	5.75	9.90	6.96
Net Income	-$10.57M	$180.93M	$3.54B	$334.92M
7 Day Performance	-32.26%	5.04%	-0.48%	-1.24%
1 Month Performance	-4.66%	1.86%	-0.82%	0.27%
1 Year Performance	-77.82%	2.93%	33.62%	33.19%

Intelligent Bio Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INBS Intelligent Bio Solutions	0.8337 of 5 stars	$2.78 -1.6%	N/A	-77.9%	$6.65M	$3.05M	N/A	10	Positive News
FEMY Femasys	2.0807 of 5 stars	$0.38 -6.7%	$5.50 +1,358.5%	-67.5%	$24.41M	$2.38M	N/A	30	Analyst Downgrade Gap Down
POAI Predictive Oncology	0.2034 of 5 stars	$6.66 +17.5%	N/A	-71.2%	$22.60M	$1.66M	N/A	30	Gap Down
RVP Retractable Technologies	N/A	$0.70 +2.4%	N/A	-6.6%	$20.96M	$38.27M	N/A	240	Gap Up
ICCM IceCure Medical	2.7995 of 5 stars	$0.24 flat	$2.64 +997.9%	-76.9%	$19.48M	$3.38M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INBS) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intelligent Bio Solutions (INBS) Competitors

INBS vs. FEMY, POAI, RVP, ICCM, and OSRH

How does Intelligent Bio Solutions compare to Femasys?

Summary

How does Intelligent Bio Solutions compare to Predictive Oncology?

Summary

How does Intelligent Bio Solutions compare to Retractable Technologies?

Summary

How does Intelligent Bio Solutions compare to IceCure Medical?

Summary

How does Intelligent Bio Solutions compare to OSR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intelligent Bio Solutions (INBS) Competitors

INBS vs. FEMY, POAI, RVP, ICCM, and OSRH

How does Intelligent Bio Solutions compare to Femasys?

Which has preferable valuation and earnings, FEMY or INBS?

Do insiders and institutionals believe in FEMY or INBS?

Is FEMY or INBS more profitable?

Which has more volatility and risk, FEMY or INBS?

Do analysts prefer FEMY or INBS?

Does the media favor FEMY or INBS?

Summary

How does Intelligent Bio Solutions compare to Predictive Oncology?

Is INBS or POAI more profitable?

Do analysts recommend INBS or POAI?

Do institutionals and insiders hold more shares of INBS or POAI?

Does the media favor INBS or POAI?

Which has better valuation and earnings, INBS or POAI?

Which has more volatility & risk, INBS or POAI?

Summary

How does Intelligent Bio Solutions compare to Retractable Technologies?

Which has more risk & volatility, RVP or INBS?

Do analysts recommend RVP or INBS?

Which has higher valuation & earnings, RVP or INBS?

Does the media prefer RVP or INBS?

Is RVP or INBS more profitable?

Do institutionals and insiders have more ownership in RVP or INBS?

Summary

How does Intelligent Bio Solutions compare to IceCure Medical?

Which has higher earnings & valuation, INBS or ICCM?

Does the media refer more to INBS or ICCM?

Which has more risk and volatility, INBS or ICCM?

Is INBS or ICCM more profitable?

Do insiders and institutionals hold more shares of INBS or ICCM?

Do analysts recommend INBS or ICCM?

Summary

How does Intelligent Bio Solutions compare to OSR?

Which has more risk and volatility, OSRH or INBS?

Does the media refer more to OSRH or INBS?

Do insiders & institutionals hold more shares of OSRH or INBS?

Do analysts rate OSRH or INBS?

Which has preferable earnings & valuation, OSRH or INBS?

Is OSRH or INBS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools